https://www.selleckchem.com/pr....oducts/gsk2126458.ht
Minimally invasive direct coronary artery bypass (MIDCA for a left internal mammary artery on left anterior descending (LIMA-LAD) graft, is a safe and relatively less traumatic surgical technique. Adoption in some centers has been slow because of perceived technical difficulty, but it should be considered a first-choice therapy for patients with isolated proximal LAD lesions or multi-vessel disease, and as a component of a hybrid revascularization strategy. Results in our institute, where we have been using MIDCAB for more than 20
Мне нравится
Комментарий
Перепост
